Kai Wu
Vice President @ CICC
Shanghai, China
Kai Wu is a Series A investor at CICC in Shanghai focused on Medical and Health Care. Wu Kai is working as Vice President for CICC Capital.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 33%
Last updated:
For AI agents: llms.txt
Industries Kai Wu invests in
Stages Kai Wu invests in
Countries Kai Wu invests in
Investment Focus
Industry
- Medical 1 (33%)
- Health Care 1 (33%)
- Therapeutics 1 (33%)
- Biotechnology 1 (33%)
- Manufacturing 1 (33%)
Stage
- Series A 2 (67%)
- Series B 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Kingwills New Materials
|
The main business of "Qingyun New Materials" is to develop, produce and sell flash-spun metamaterial Kunlun® Hypak® , which is a high-strength, waterproof and breathable special fiber material that is arranged in the form of non-woven fabrics. | $14.8M / Series A / Jun 14, 2022 | |
Xinjunte
|
Xinjunte has focused on the research and development of intelligent medical devices for bone surgery, and is committed to providing more efficient and safe medical devices. | Series B / Nov 01, 2021 | |
Reforgene Medicine
|
Reforgene Medicine is a biomedical company that uses gene editing and genomic technology to develop new drugs intended to cure genetic diseases. | Series A / Sep 16, 2021 |
Co-Investors
ABC International
1 deal together
Asia Green Fund
1 deal together
Oriental Yuhong
1 deal together
BioTrack Capital
1 deal together
BioVenture
1 deal together
China Merchants Securities
1 deal together
About CICC
Established in 1995 as the first joint venture investment bank in China, China International Capital Corporation Limited (CICC) is a leader in providing comprehensive financial services including investment banking, capital markets, institutional and individual securities sales and trading, fixed income, asset management, private equity, individualwealth management and research.
CICC Contacts
| Name | Phone | Socials | |
|---|---|---|---|
David Zhang
Vice President
|
|||
|
Jiang, Xingquan
Managing Director
|
|||
|
Kai Wu
Vice President
|
|||
|
Lei Yin
Vice President; Executive Director
|
|||
Levin Zhu
CEO & President
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Kai Wu invest in?
Kai Wu invests primarily in Medical, Health Care and Therapeutics startups, most often at Series A and Series B stage. Most of the 3 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Kai Wu last invest?
The most recent investment recorded for Kai Wu closed in Jun 2022. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
